Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Two Considerations - 80% of Revenue going to TPL..a quick look at the last
24
Mar 24, 2010 11:58AM
8
Mar 24, 2010 12:50PM
1
Mar 24, 2010 01:05PM
3
Mar 24, 2010 01:43PM
2
Mar 24, 2010 01:56PM
4
Mar 24, 2010 04:10PM
1
Mar 24, 2010 04:36PM

10Q shows that for that quarter PTSC showed licensing income of about 43% of the gross licensing amount for the quarter, which means overall the profit of PDS was about 86% of gross licensing. For the 6 months it equated to 63%. So obviously your 80/20 info in misinformation.

5
Mar 24, 2010 05:52PM
2
Mar 24, 2010 06:21PM
6
Mar 24, 2010 07:02PM
1
Mar 24, 2010 08:21PM
Share
New Message
Please login to post a reply